Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more
Healthcare Global Enterprises Limited (HCG) - Total Assets
Latest total assets as of September 2025: ₹35.86 Billion INR
Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) holds total assets worth ₹35.86 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Healthcare Global Enterprises Limited - Total Assets Trend (2011–2025)
This chart illustrates how Healthcare Global Enterprises Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Healthcare Global Enterprises Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Healthcare Global Enterprises Limited's total assets of ₹35.86 Billion consist of 23.8% current assets and 76.2% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹1.07 Billion | 6.7% |
| Accounts Receivable | ₹4.04 Billion | 11.4% |
| Inventory | ₹530.20 Million | 1.5% |
| Property, Plant & Equipment | ₹19.88 Billion | 56.1% |
| Intangible Assets | ₹489.10 Million | 1.4% |
| Goodwill | ₹4.30 Billion | 12.1% |
Asset Composition Trend (2011–2025)
This chart illustrates how Healthcare Global Enterprises Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Healthcare Global Enterprises Limited's current assets represent 23.8% of total assets in 2025, an increase from 13.0% in 2011.
- Cash Position: Cash and equivalents constituted 6.7% of total assets in 2025, up from 1.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 2.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 56.1% of total assets.
Healthcare Global Enterprises Limited Competitors by Total Assets
Key competitors of Healthcare Global Enterprises Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Healthcare Global Enterprises Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Healthcare Global Enterprises Limited generates 0.63x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Healthcare Global Enterprises Limited generates $ 1.25 in net profit.
Healthcare Global Enterprises Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.73 | 0.90 | 0.70 |
| Quick Ratio | 0.68 | 0.84 | 0.66 |
| Cash Ratio | 0.18 | 0.33 | 0.00 |
| Working Capital | ₹-2.76 Billion | ₹ -825.00 Million | ₹ -1.67 Billion |
Healthcare Global Enterprises Limited - Advanced Valuation Insights
This section examines the relationship between Healthcare Global Enterprises Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.66 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 30.9% |
| Total Assets | ₹35.43 Billion |
| Market Capitalization | $318.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Healthcare Global Enterprises Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Healthcare Global Enterprises Limited's assets grew by 30.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Healthcare Global Enterprises Limited (2011–2025)
The table below shows the annual total assets of Healthcare Global Enterprises Limited from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹35.43 Billion | +30.87% |
| 2024-03-31 | ₹27.07 Billion | +16.90% |
| 2023-03-31 | ₹23.16 Billion | +4.35% |
| 2022-03-31 | ₹22.20 Billion | +9.03% |
| 2021-03-31 | ₹20.36 Billion | -9.66% |
| 2020-03-31 | ₹22.53 Billion | +36.26% |
| 2019-03-31 | ₹16.54 Billion | +14.54% |
| 2018-03-31 | ₹14.44 Billion | +17.71% |
| 2017-03-31 | ₹12.26 Billion | +17.52% |
| 2016-03-31 | ₹10.44 Billion | +37.71% |
| 2015-03-31 | ₹7.58 Billion | +10.04% |
| 2014-03-31 | ₹6.89 Billion | -2.87% |
| 2013-03-31 | ₹7.09 Billion | +28.50% |
| 2012-03-31 | ₹5.52 Billion | +42.01% |
| 2011-03-31 | ₹3.89 Billion | -- |